# Graham Holdings Co: financial statements, quarterly

GHC · NYSE · CIK 104889 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ghc.md) · [Financials](/companies/ghc/financials.md) · [Filings](/companies/ghc/filings.md) · [Insiders](/companies/ghc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ghc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,167](/filings/0000104889-24-000010.md) | [1,153](/filings/0000104889-25-000032.md) | [1,185](/filings/0000104889-25-000062.md) | [1,207](/filings/0001628280-25-046925.md) | [1,246 d](/filings/0001628280-26-011405.md) | [1,166](/filings/0000104889-25-000032.md) | [1,216](/filings/0001628280-26-050826.md) | [1,279](/filings/0001628280-26-068026.md) | [1,251 d](/filings/0001628280-26-011405.md) | not reported | [1,303](/filings/0001628280-26-050826.md) | [1,326](/filings/0001628280-26-068026.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [40.8](/filings/0000104889-24-000010.md) | [35.4](/filings/0000104889-25-000032.md) | [25.9](/filings/0000104889-25-000062.md) | [81.6](/filings/0001628280-25-046925.md) | [72.5 d](/filings/0001628280-26-011405.md) | [47.5](/filings/0000104889-25-000032.md) | [72.8](/filings/0001628280-26-050826.md) | [67.1](/filings/0001628280-26-068026.md) | [47.6 d](/filings/0001628280-26-011405.md) | not reported | [83.6](/filings/0001628280-26-050826.md) | [85.5](/filings/0001628280-26-068026.md) |
| Interest expense | $m | [25.4 d](/filings/0000104889-24-000010.md) | [19.3](/filings/0000104889-24-000016.md) | [91.4](/filings/0000104889-25-000062.md) | [25.9](/filings/0001628280-25-046925.md) | [49.5 d](/filings/0001628280-26-011405.md) | [82.3](/filings/0000104889-25-000032.md) | [18.1](/filings/0001628280-26-050826.md) | [17.2](/filings/0001628280-26-068026.md) | [1.2 d](/filings/0001628280-26-011405.md) | not reported | [17.2](/filings/0001628280-26-050826.md) | [15.8](/filings/0001628280-26-068026.md) |
| Income tax | $m | [16.9 d](/filings/0001628280-26-011405.md) | [43.5](/filings/0000104889-25-000032.md) | [4.1](/filings/0000104889-25-000062.md) | [38.5](/filings/0001628280-25-046925.md) | [206 d](/filings/0001628280-26-011405.md) | [7.9](/filings/0000104889-25-000032.md) | [20.2](/filings/0001628280-26-050826.md) | [56.8](/filings/0001628280-26-068026.md) | [61.5 d](/filings/0001628280-26-011405.md) | not reported | [35.1](/filings/0001628280-26-050826.md) | [21.9](/filings/0001628280-26-068026.md) |
| Net income | $m | [53.3](/filings/0000104889-24-000010.md) | [124](/filings/0000104889-25-000032.md) | [(21.0)](/filings/0000104889-25-000062.md) | [72.5](/filings/0001628280-25-046925.md) | [549 d](/filings/0001628280-26-011405.md) | [23.9](/filings/0000104889-25-000032.md) | [36.7](/filings/0001628280-26-050826.md) | [123](/filings/0001628280-26-068026.md) | [109 d](/filings/0001628280-26-011405.md) | [30.8](/filings/0001628280-26-068026.md) | [281](/filings/0001628280-26-050826.md) | [75.1](/filings/0001628280-26-068026.md) |
| Diluted EPS | $ per share | [11.72](/filings/0000104889-24-000010.md) | [27.72](/filings/0000104889-25-000032.md) | [(4.79)](/filings/0000104889-25-000062.md) | [16.42](/filings/0001628280-25-046925.md) | not reported | [5.45](/filings/0000104889-25-000032.md) | [8.35](/filings/0001628280-26-050826.md) | [27.91](/filings/0001628280-26-068026.md) | not reported | not reported | [64.86](/filings/0001628280-26-050826.md) | [17.60](/filings/0001628280-26-068026.md) |
| Basic EPS | $ per share | [11.76](/filings/0000104889-24-000010.md) | [27.87](/filings/0000104889-25-000032.md) | [(4.79)](/filings/0000104889-25-000062.md) | [16.54](/filings/0001628280-25-046925.md) | not reported | [5.50](/filings/0000104889-25-000032.md) | [8.43](/filings/0001628280-26-050826.md) | [28.19](/filings/0001628280-26-068026.md) | not reported | not reported | [65.53](/filings/0001628280-26-050826.md) | [17.79](/filings/0001628280-26-068026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [170](/filings/0000104889-25-000022.md) | [131](/filings/0000104889-24-000016.md) | [141](/filings/0000104889-24-000041.md) | [244](/filings/0000104889-24-000065.md) | [261](/filings/0001628280-26-011405.md) | [157](/filings/0000104889-25-000032.md) | [176](/filings/0000104889-25-000062.md) | [191](/filings/0001628280-25-046925.md) | [267](/filings/0001628280-26-068026.md) | not reported | [157](/filings/0001628280-26-050826.md) | [154](/filings/0001628280-26-068026.md) |
| Current assets | $m | [1,849](/filings/0000104889-25-000022.md) | [1,951](/filings/0000104889-24-000016.md) | [1,939](/filings/0000104889-24-000041.md) | [2,085](/filings/0000104889-24-000065.md) | [2,099](/filings/0001628280-26-011405.md) | [2,027](/filings/0000104889-25-000032.md) | [2,010](/filings/0000104889-25-000062.md) | [2,243](/filings/0001628280-25-046925.md) | [2,431](/filings/0001628280-26-068026.md) | not reported | [2,271](/filings/0001628280-26-050826.md) | [2,357](/filings/0001628280-26-068026.md) |
| Total assets | $m | [7,188](/filings/0000104889-25-000022.md) | [7,255](/filings/0000104889-24-000016.md) | [7,234](/filings/0000104889-24-000041.md) | [7,421](/filings/0000104889-24-000065.md) | [7,677](/filings/0001628280-26-011405.md) | [7,616](/filings/0000104889-25-000032.md) | [7,619](/filings/0000104889-25-000062.md) | [7,852](/filings/0001628280-25-046925.md) | [8,396](/filings/0001628280-26-068026.md) | not reported | [8,141](/filings/0001628280-26-050826.md) | [8,290](/filings/0001628280-26-068026.md) |
| Current liabilities | $m | [1,230](/filings/0000104889-25-000022.md) | [1,242](/filings/0000104889-24-000016.md) | [1,208](/filings/0000104889-24-000041.md) | [1,332](/filings/0000104889-24-000065.md) | [1,200](/filings/0001628280-26-011405.md) | [1,250](/filings/0000104889-25-000032.md) | [1,579](/filings/0000104889-25-000062.md) | [1,693](/filings/0001628280-25-046925.md) | [1,389](/filings/0001628280-26-068026.md) | not reported | [1,221](/filings/0001628280-26-050826.md) | [1,340](/filings/0001628280-26-068026.md) |
| Total liabilities | $m | [3,162](/filings/0000104889-25-000022.md) | [3,160](/filings/0000104889-24-000016.md) | [3,201](/filings/0000104889-24-000041.md) | [3,350](/filings/0000104889-24-000065.md) | [3,347](/filings/0001628280-26-011405.md) | [3,247](/filings/0000104889-25-000032.md) | [3,185](/filings/0000104889-25-000062.md) | [3,311](/filings/0001628280-25-046925.md) | [3,529](/filings/0001628280-26-068026.md) | not reported | [3,320](/filings/0001628280-26-050826.md) | [3,452](/filings/0001628280-26-068026.md) |
| Long-term debt | $m | [745](/filings/0000104889-25-000022.md) | [739](/filings/0000104889-24-000016.md) | [733](/filings/0000104889-24-000041.md) | [731](/filings/0000104889-24-000065.md) | [722](/filings/0001628280-26-011405.md) | [715](/filings/0000104889-25-000032.md) | [314](/filings/0000104889-25-000062.md) | [307](/filings/0001628280-25-046925.md) | [706](/filings/0001628280-26-068026.md) | not reported | [709](/filings/0001628280-26-050826.md) | [705](/filings/0001628280-26-068026.md) |
| Current portion of debt | $m | [66.8](/filings/0000104889-25-000022.md) | [76.8](/filings/0000104889-24-000016.md) | [102](/filings/0000104889-24-000041.md) | [34.1](/filings/0000104889-24-000065.md) | [26.6](/filings/0001628280-26-011405.md) | [149](/filings/0000104889-25-000032.md) | [502](/filings/0000104889-25-000062.md) | [425](/filings/0001628280-25-046925.md) | [175](/filings/0001628280-26-068026.md) | not reported | [191](/filings/0001628280-26-050826.md) | [148](/filings/0001628280-26-068026.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [3,976](/filings/0000104889-25-000022.md) | [4,043](/filings/0000104889-24-000016.md) | [3,968](/filings/0000104889-24-000041.md) | [4,004](/filings/0000104889-24-000065.md) | [4,257](/filings/0001628280-26-011405.md) | [4,294](/filings/0000104889-25-000032.md) | [4,352](/filings/0000104889-25-000062.md) | [4,457](/filings/0001628280-25-046925.md) | [4,794](/filings/0001628280-26-068026.md) | [4,767](/filings/0001628280-26-068026.md) | [4,762](/filings/0001628280-26-050826.md) | [4,778](/filings/0001628280-26-068026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.4 d](/filings/0000104889-24-000041.md) | [140 d](/filings/0000104889-24-000065.md) | [57.3 d](/filings/0001628280-26-011405.md) | [1.1](/filings/0000104889-25-000032.md) | [52.0 d](/filings/0000104889-25-000062.md) | [238 d](/filings/0001628280-25-046925.md) | [116 d](/filings/0001628280-26-011405.md) | [46.0](/filings/0000104889-25-000032.md) | [94.8 d](/filings/0001628280-26-050826.md) | [178 d](/filings/0001628280-26-068026.md) | [28.3 d](/filings/0001628280-26-011405.md) | [160 d](/filings/0001628280-26-068026.md) |
| Capital expenditure | $m | [18.4 d](/filings/0000104889-24-000041.md) | [20.2 d](/filings/0000104889-24-000065.md) | [32.3 d](/filings/0001628280-26-011405.md) | [21.3](/filings/0000104889-25-000032.md) | [18.3 d](/filings/0000104889-25-000062.md) | [18.1 d](/filings/0001628280-25-046925.md) | [25.2 d](/filings/0001628280-26-011405.md) | [15.5](/filings/0000104889-25-000032.md) | [16.8 d](/filings/0001628280-26-050826.md) | [16.3 d](/filings/0001628280-26-068026.md) | [23.3 d](/filings/0001628280-26-011405.md) | [25.8 d](/filings/0001628280-26-068026.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [45.6 d](/filings/0000104889-24-000041.md) | [63.2 d](/filings/0000104889-24-000065.md) | [60.9 d](/filings/0001628280-26-011405.md) | [20.0](/filings/0000104889-25-000032.md) | [29.5 d](/filings/0000104889-25-000062.md) | [48.7 d](/filings/0001628280-25-046925.md) | [15.9 d](/filings/0001628280-26-011405.md) | [3.5](/filings/0000104889-25-000032.md) | [0.0 d](/filings/0001628280-26-050826.md) | [0.0 d](/filings/0001628280-26-068026.md) | [0.0 d](/filings/0001628280-26-011405.md) | [76.6 d](/filings/0001628280-26-068026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,820](/filings/0000104889-23-000064.md) | [4,776](/filings/0000104889-24-000016.md) | [4,713](/filings/0000104889-24-000041.md) | [4,602](/filings/0000104889-24-000065.md) | [4,457](/filings/0000104889-25-000032.md) | [4,401](/filings/0000104889-25-000062.md) | [4,384](/filings/0001628280-25-046925.md) | [4,358](/filings/0000104889-25-000032.md) | [4,373](/filings/0001628280-26-050826.md) | [4,378](/filings/0001628280-26-068026.md) | [4,309](/filings/0001628280-26-050826.md) | [4,243](/filings/0001628280-26-068026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:37 ET. No prices; not investment advice.